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ABSTRACT 
Protein-energy malnutrition (PEM) has been found in up to 16.3% of acute stroke 
patients upon admission to hospital.  Our laboratory has previously shown that PEM 
impairs functional outcome in a gerbil model of global ischemia, but the mechanism 
has not been established.  The purpose of the current study was to characterize the 
marked reactive gliosis apparent in a subset of these animals that could represent an 
increased inflammatory response.  A second objective was to validate a screening 
protocol for assessing completeness of ischemia in this model.   
Male Mongolian gerbils, aged 11-12 weeks, were randomized to PEM (2% protein) 
or control diet (12.5% protein) for 28d.  PEM animals lost 12.2% of their initial 
body weight, and feed intake and serum albumin concentration were 12.3% and 
17.8% lower than controls, respectively.  At day 28, animals underwent 5 min 
bilateral common carotid artery occlusion (ischemia) or sham surgery.  Activity was 
monitored using infrared beam interruptions for 20h post-surgery to screen for 
complete ischemia on the basis of persistent hyperactivity.  Brain sections were 
stained with hematoxylin & eosin, and viable hippocampal CA1 neurons were 
counted at 10d post-ischemia.  Immunohistochemistry for glial-fibrillary acidic 
protein (GFAP) and  ricinus communis agglutinin -120 (RCA-120), markers for 
astrocytes and microglia, respectively, and the inflammatory cytokine TNF-alpha 
was performed on brain sections at 6h, 24h, 3d and 10d post-surgery (Ischemic, n=8; 
Sham, n=3).  The activity monitoring procedure for detecting complete ischemia 
validated against hippocampal CA1 neuronal loss at 10d demonstrated an accuracy 
of 84.6%.  Temporal changes in GFAP and RCA-120 immunoreactivity 
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characteristic of reactive gliosis were demonstrated following ischemia, but this was 
not exacerbated by PEM.  TNF-alpha immunoreactivity following ischemia was also 
unaltered by PEM.  Ischemia significantly reduced surviving CA1 neurons at 10 
days post-ischemia (two-way ANOVA; p<0.05), but this was not influenced by 
PEM.  Impaired functional outcome in PEM animals following global ischemia can 
not be accounted for by increased hippocampal CA1 neuron death or by altered glial 
response.   
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CHAPTER 1.  INTRODUCTION 
1.1 Rationale 
The Canadian population is aging (1).  It has been estimated that the proportion 
of Canadians over the age of 65 will increase from 13% in 2001 to 21% by the year 
2026 (1).  After the age of 55, stroke risk doubles every 10 years (2).  Stroke patients 
may require long term care, and the quality of life of stroke survivors is often 
reduced (2).  One of the priority topic areas for the Institute of Aging of the 
Canadian Institutes of Health Research is quality of life (1).  To date there is no 
effective treatment to prevent brain damage arising from stroke (3).  In order to find 
an effective treatment, it is crucial that factors that could worsen stroke outcome are 
identified and their mechanisms elucidated.  Recent studies suggest that stroke 
patients that were malnourished before having a stroke had worse clinical outcomes 
than patients that were well nourished (4-8).  This suggests that undernutrition may 
play a role in exacerbating brain injury following stroke.   
A recent study conducted in our laboratory (9,10) has demonstrated a causal 
relationship between protein-energy malnutrition (PEM) and poor stroke outcome in 
an animal model of stroke.  Gerbils with PEM that were subjected to global ischemia 
had significantly worse behavioural outcomes, as assessed by open field, when 
compared to ischemic animals fed control diet.  Although PEM did not worsen the 
loss of hippocampal CA1 neurons at day 10 post-ischemia, one third of the PEM 
animals showed marked gliosis that completely disrupted the CA1 pyramidal neuron 
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region.  Sections immunostained with anti-glial fibrillary acidic protein (GFAP) 
antibody suggested that this subset of PEM ischemic animals had a large population 
of reactive astrocytes (unpublished observations).  A limitation of this study is that 
the sections had first been stained with hematoxylin and eosin (H & E).  This 
reduced sensitivity such that it was not possible to immunohistochemically detect 
whether there were also increased numbers of activated microglia present.  Increased 
reactive gliosis post-ischemia, if confirmed, may be indicative of an increased 
inflammatory response in PEM (10).   In order to ascertain the effect of PEM on 
astrocytic and microglial activation following global ischemia, this study needs to be 
repeated with appropriate tissue sections.   
At the time the study was conducted, evidence was also accumulating that 
cerebral vasculature was changing in gerbils from commercial suppliers, resulting in 
a marked increase in variability of ischemic brain damage in the model of global 
ischemia used in our laboratory (11).  Thus, a method for selecting animals that had 
been exposed to complete (severe) ischemia also needed to be developed.  Previous 
research suggested that the persistent hyperactivity that follows severe global 
ischemia in the gerbil (12) could provide a noninvasive way to identify these 
animals. 
1.2 Hypothesis 
 
PEM exacerbates reactive gliosis and inflammation occurring in response to 
global ischemia. 
1.3 Objectives 
 
The objectives of this research are as follows:  
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1. To investigate the temporal response of markers of reactive gliosis and 
inflammation to 5 minute common carotid artery occlusion (global ischemia) 
in the gerbil as compared to sham controls.  
2. To determine if PEM increases reactive gliosis in global ischemia. 
3. To determine if PEM exacerbates inflammation in global ischemia. 
4. To confirm the effect of PEM on hippocampal CA1 neuronal counts in 
global ischemia. 
5. To validate the measurement of persistent hyperactivity against hippocampal 
CA1 neuronal counts as a method of screening for complete global ischemia 
in the gerbil.   
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CHAPTER 2.  REVIEW OF LITERATURE 
2.1 Introduction 
Stroke, which is defined as a disruption in cerebral blood flow (13), afflicts 
between 40,000 and 50,000 Canadians every year (2).  Cerebrovascular diseases 
rank as the third leading cause of death in Canada, following cancer and heart 
disease (14).  Each year the Canadian Health Care System spends $2.7 billion on 
costs associated with stroke patients (2).  To date there is no effective treatment to 
prevent brain damage arising from stroke (3).  The only accepted therapy for acute 
stroke is intravenous recombinant tissue plasminogen activator administered within 
three hours of stroke, but this therapy is not neuroprotective and in order to be 
effective needs to be initiated within 3 hours of the start of the stroke (3).  The 
limitations of this treatment mean that few patients qualify to be treated.  In order to 
develop effective treatments, it is also crucial to identify factors that could 
exacerbate brain injury associated with stroke.  Undernutrition, which is present in a 
large proportion of acute stroke patients, may play a role in stroke development and 
outcome (4,15).     
A recent study conducted in our laboratory (9,10) has demonstrated a causal 
relationship between protein-energy malnutrition (PEM) and poor functional 
(behavioural) outcome in an animal model of stroke.  Although the mechanism(s) for 
this are unknown, an increased inflammatory response may be a contributor  (10). 
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2.2 Protein-Energy Malnutrition and Stroke 
2.2.1  Prevalence of PEM in Stroke Patients 
Most stroke patients are elderly (16).  After the age of 55, stroke risk doubles 
every 10 years (2).  This population is more at risk for undernutrition, including 
protein-energy malnutrition (PEM) (7).  PEM is a comprehensive term used to refer 
to the situation when the requirement for protein and energy is not met (17).The 
tools used to measure PEM in the many different stroke studies are inconsistent, 
making it difficult to make comparisons between studies.  Tests of PEM include 
dietary assessment, anthropometry, and static biochemical and functional indices 
(18).  In hospitalized patients, the identification of PEM is difficult because many of 
the tests used to detect PEM can be affected by pre-existing conditions, such as 
inflammation (18).  Tests of nutritional status using a single indicator have limited 
use for identifying PEM in patients; multi-parameter screening tests, or scoring 
systems, may be more effective for its identification (18).  Serum albumin is the 
most common serum protein used to detect PEM (18).  Although serum albumin is 
nonspecific, it has been found to be a strong independent predictor of mortality in 
hospitalized stroke patients (6,7).  Other biochemical tests that can be used to detect 
PEM are serum transferrin, white blood cell count, total lymphocyte count, 24-hr 
urinary urea nitrogen, 24-hr urinary creatinine, creatinine height index, and more 
recently, serum transthyretin (18).  Anthropometric indicators of PEM commonly 
used are weight loss, body mass index (BMI), triceps skin-fold thickness, and upper 
arm muscle circumference (18).  Functional tests that can be used to detect PEM are 
tests of muscle weakness, such as hand grip strength, respiratory muscle weakness, 
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poor wound healing, depression, irritability and fatigue, and delayed hypersensitivity 
testing (18).  Examples of multi-parameter screening tools used to detect PEM are 
the prognostic nutritional index, the nutrition risk index, the mini nutritional 
assessment (MNA), and subjective global assessment (18).   
Despite these limitations in assessment tools used, several estimates of the 
prevalence of PEM in acute stroke patients have been made.  In a study by Davalos 
et al. (4), 104 acute stroke patients were immediately assessed for nutritional status 
on admission and then weekly during hospitalization.  Nutritional status was 
assessed by measuring triceps skin-fold thickness (TSF), mid-arm muscle 
circumference (MAMC), and serum albumin concentration.  They found that 16.3% 
of patients at admission and 26.4% after the first week had protein-energy 
malnutrition.  Malnutrition was associated with an increased stress reaction during 
the first week, increased incidence of respiratory and urinary tract infections and 
bedsores, increased mortality, worse outcomes and longer duration of hospital stay.  
Axelsson and colleagues (19) looked at the nutritional status of 100 stroke patients 
within the first 4 days of admission to hospital.  Nutritional status was assessed by 
measuring body weight, triceps skin-fold thickness and upper arm muscle 
circumference (AMC) using the right arm, plasma albumin and prealbumin, as well 
as serum transferrin.  Of the 100 patients, 16% were malnourished upon admission, 
and of the 78 patients remaining at discharge, 23% were malnourished.  Unosson 
and colleagues (20) found that 8% of stroke patients had PEM and 62% had low 
serum albumin values within 48 hours of admission.  The patients were classified as 
having PEM if they met certain criteria for the following variables:  weight index, 
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triceps skin-fold thickness and upper arm muscle circumfrence using the left arm 
except when the left arm was paralyzed, serum transthyretin, albumin and α1-
antitrypsin, and delayed hypersensitivity skin testing (DHT).  Choi-Kwon et al. (15) 
studied the nutritional status of 88 Korean female stroke patients (67 with cerebral 
infarction and 21 with intra-cerebral hemorrhage) admitted to hospital with their first 
stroke.  Nutritional status was assessed by measuring BMI upon admission, TSF, 
sub-scapular skin-folds thickness (SSF), abdominal skin-folds thickness (ASF), and 
lean body mass (LBM) within one week of admission, and blood lymphocyte count, 
hemoglobin and serum albumin within 24 hours of admission.  62% of patients with 
intra-cerebral hemorrhage, 25% of patients with cerebral infarction and 13% of 
healthy age-matched controls were malnourished.  This study found a very high 
incidence of malnutrition in female stroke patients compared to other studies, but 
this may be because the nutritional assessment was not conducted upon admission in 
all subjects; anthropometric measurements were taken up to one week following 
admission.  Davis and colleagues (5) used subjective global assessment (SGA) 
within 24 hours of admission on 185 acute stroke patients and found that 16% of 
these patients were malnourished.  Crude analysis found that malnourished patients 
were significantly more likely to die or have poor outcomes than the well-nourished 
patients; this was not significant after adjustment for other prognostic factors such as 
age, pre-morbid dependence, and stroke severity.  Low serum albumin 
concentrations upon admission were significantly associated with pre-morbid 
nutrition and mortality at one month post-stroke, but not with poor outcome at the 
same time point.             
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Elderly patients are already at increased risk for co-existing PEM at the time 
of admission for stroke due to factors in their previous medical history.  These can 
include reduced nutritional reserves, prolonged hospital stays, increased demands of 
repeated ill health, dysphagia, poor nutritional support, prolonged inactivity, and 
functional disability (4,6,7,15).  The prevalence of PEM becomes even higher in the 
elderly post-stroke (4,6,7,19,21).  One reason for this is decreased ability to eat 
following stroke (4,21).   
Low serum albumin concentrations have been implicated with a negative 
prognosis in stroke patients (18).  Serum albumin is used as a nonspecific marker for 
protein status because the latter is only one of several regulators of albumin 
synthesis (6,7).  In two observational prospective studies (6,7) that measured serum 
albumin concentrations in patients admitted to hospital with stroke, low serum 
albumin concentration, after adjustment was made for other prognostic factors, was a 
strong predictor of death following hospitalization.  These studies also looked at 
anthropometric measures such as triceps and biceps skin fold and mid arm 
circumference to assess nutritional status, but these variables were not correlated 
with stroke outcome.  Preliminary analysis of the first 3012 patients admitted to 
hospital with recent stroke from the FOOD (Feed or Ordinary Food) trial (8), a series 
of international multi-centre randomized trials, suggested that undernourished 
patients had decreased chance of survival, functional ability and living 
circumstances at six months follow-up.  Unfortunately, this series of studies had one 
major limitation, which was a lack of standardization for the nutritional assessment.  
Clinicians categorized the patients into underweight, overweight and normal based 
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on a bedside assessment and only in some instances did this include weight, height, 
dietary history or blood tests.  Only 9% of the study population was judged to be 
malnourished upon admission to hospital.  The low prevalence of PEM found in this 
study compared to other studies may be due to their poor nutritional assessment 
strategy.  These studies also did not assess nutritional status after nutritional 
interventions, nor was actual nutrient intake recorded (22-24).  Upon completion, the 
FOOD trials did not adequately test the hypothesis of a causal relationship between 
compromised nutritional status and stroke outcome  (22,23).  Thus, the full extent to 
which undernutrition and PEM contribute to stroke outcome is not yet known (7).  
However, a study from our laboratory in an animal model of stroke suggests that 
there is a direct link (10). 
Although the tools used to assess PEM in elderly stroke patients have 
limitations, most of the studies estimating the prevalence of PEM arrive at a similar 
number.  Of the tools that could be used to assess PEM, only the mini nutritional 
assessment was designed specifically for use in the elderly (18), but it has not been 
used to date in stroke studies.  The original mini nutritional assessment uses 18 
indices grouped into anthropometric assessment, general assessment, dietary 
assessment, and subjective assessment (18).  The final score from these four groups 
is totaled and used to categorize patients as normal, at risk for malnutrition, or 
undernourished (18).  A new version of the mini nutritional assessment uses a two 
step approach; the first step is used to screen for potential malnutrition and if 
patients fail this step, then the second step is used to assess malnutrition, and groups 
patients into either malnourished or at risk of malnutrition (18).  The mini nutritional 
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assessment would be the best way to assess PEM in future studies with elderly 
stroke patients because it is the only one designed and validated for use in the elderly 
and it is a multi-parameter tool.  If time is an issue, the new version of this tool may 
be more beneficial.    
2.2.2 Modeling of PEM in Elderly Stroke Patients 
 
PEM in industrialized countries occurs in the elderly, as well as in 
institutionalized and hospitalized adults (25-28).  Decreased nutrient intake, physical 
activity levels, lean body mass and basal metabolic energy requirements occur 
naturally with healthy aging (29-34).  As a result, elderly individuals can become 
protein-energy malnourished from decreased consumption of energy and protein; 
conversely, they may be subject to obesity if they continue to consume the same 
amount of energy as they did when they were younger (30).  Physiological and 
pathophysiological changes that occur with aging that contribute to decreased energy 
intake are decreased olfactory and taste thresholds, gastro-intestinal changes, 
prevalence of chronic illness, physical impairments that hinder the ability to shop for 
and prepare food, increased medication use, poor dentition, depression, isolation and 
dementia (30-34).  Chronic illness and medications can increase nutrient 
requirements as well (32,33).   
In a study by De Castro (29), a convenience sample, which is a sample of 
volunteers, of 167 healthy adult males and 140 healthy adult females was used to 
study age-related changes in food intake.  All subjects were instructed to keep a 7 
day food diary detailing what they ate or drank, the time it was eaten, the amount 
eaten, how the item was prepared, the number of people that ate with them, their 
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subjective state of pre- and post-meal hunger, thirst, mental state and pre-meal 
activity levels.  Subjects’ intakes were verified by contacting individuals that had 
eaten with them during the study period.  Subjects that were aged 50-80 ate 12% 
fewer Calories than subjects aged 20-49.  This decrease in caloric intake was due to 
a decrease in both fat and protein intake and smaller meals, in general.  The older 
subjects also reported feeling more elated at meal times, less anxious, and being less 
active than the younger groups.  This may suggest that when the healthy elderly 
individual becomes unhealthy that they will be more likely to become malnourished.  
Overall, the reductions in energy intake were more marked for males than females.  
This study also found that external stimuli are more important for intake in the 
elderly than the subjective state of hunger.  The results of this study do, however, 
have some limitations due to selection bias and self-reporting of results.   
Endocrine changes may explain some of the decrease in food intake in the 
elderly population (31-34).  Increased circulating concentrations of cholecystokinin, 
which is a satiating hormone, are found in the elderly (31-34).  Dynorphin mediates 
the opioid feeding drive and participates in regulating fat intake (31,33,34).  Aging is 
associated with decreased opioid receptors, which would lead to a decrease in the 
opioid feeding drive (31,33,34).  Neuropeptide Y may be less effective in 
stimulating food intake in the elderly (31,34).  Insulin increases with age, as a result 
of insulin resistance, may be satiating (31,34), and the co-secretion of amylin with 
age may act as an anorectic agent (31).  In general, testosterone increases food intake 
and estrogen decreases it (31).  Testosterone levels decrease with aging and may 
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play a role in the reduction in energy intake that occurs with aging, especially in men 
(31,34).   
Common characteristics of PEM in the elderly are impaired muscle function, 
reduced heart muscle mass, decreased bone mass, immune dysfunction, poor wound 
healing, delayed surgical recovery, skin thinning, fatigue, apathy, hypothermia, 
anemia, reduced cognitive function, and increased mortality (34-36).  Weight loss is 
also characteristic of PEM in the elderly; a 10% weight reduction from usual body 
weight may indicate PEM (33).         
Current terminology utilizes the comprehensive term, protein-energy 
malnutrition, to refer to the situation when the requirement for protein and energy is 
not met (17).  Upon diagnosis of PEM, it can be classified as mild, moderate or 
severe, and as acute or chronic (17).  The diagnosis of severity and course or 
duration of PEM is usually done using anthropometry (17).  Unfortunately, the 
available terminology and grading scheme for assessing the type and degree of PEM 
has been largely derived from studies of more severe malnutrition in children in 
which growth can be assessed, and thus these standards are not relevant for assessing 
PEM in elderly stroke patients.  Weight for height is seen as the best measure to 
determine current nutritional status and height for age to determine past nutritional 
status (17).  Wasting is the term used for a weight for height deficit and stunting is 
used for a deficit in height for age (17).  Using these indexes, patients can be 
classified as i) normal, ii) wasted but not stunted (acute PEM), iii) wasted and 
stunted (acute and chronic PEM), and iv) stunted but not wasted (had PEM in the 
past, and are at present adequately nourished) (17). In adults, the BMI is the 
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anthropometric measure best used to assess severity of PEM (17). Weight loss is the 
most predominant clinical manifestation of mild to moderate PEM, and adults show 
a decrease in subcutaneous fat and lean body composition (17).  Mild to moderate 
PEM does not give consistent biochemical changes (17).  Low protein intakes could 
lead to low urinary excretion of creatinine, urea nitrogen and hydroxyproline, altered 
plasma free amino acids, with a decrease of branched-chain essential amino acids 
and slight decreases in serum transferrin and albumin, as well as a reduced number 
of circulating lymphocytes (17).  Studies focusing on PEM in stroke patients at 
admission have not classified severity of PEM, although the data suggest that it is 
mild to moderate.   
In contrast to the milder forms of PEM described in elderly individuals in 
North America, the terms, kwashiorkor and marasmus, are used to refer to the 
extreme forms of PEM found most often in children of developing countries (26-
28,37).  The diagnosis of severe PEM, including marasmus and kwashiorkor, is 
based on dietary history and clinical features (17).  Marasmus is the most common 
form of malnutrition in times of famine and leads slowly to death (26).  
Characteristics of marasmus are thinness, a weight loss of more than 20% of initial 
body weight, fatigue, irritability, a triangular face, amenorrhea, extended abdomen, 
anal or rectal prolapse, severe loss of muscle and adipose tissue, low body 
temperature, decreased pulse and metabolic rate, constipation and occasionally 
starvation diarrhea (26-28,37).  Marasmus represents a form of adaptation to 
starvation, it is normally well tolerated by adults (27,28).  Kwashiorkor occurs in the 
presence of severe protein deprivation and is not as well understood as marasmus 
 14
(26-28). Characteristics of kwashiorkor include edema, hair and skin discolouration, 
changes in mucous membranes, tongue papillae atrophy, loss of muscle tone, 
hepatomegaly, lethargy, apathy, irritability, severe immune deficiency, stunted 
growth, fatty liver, decreased serum transferrin and glutathione, and in its worst case 
coma and death (26-28,37).  In contrast to marasmus, kwashiorkor can be seen as a 
failure to adapt to malnutrition (28). 
When insufficient energy and protein are supplied (25,28), the initial source 
of amino acids for increased gluconeogenesis is smooth muscle from the gut; 
however, skeletal muscle quickly becomes the main source of amino acids (26,28).  
Decreased food intake leads to reduced plasma amino acid and glucose 
concentrations, which cause a reduction in insulin secretion and an increase in 
glucagon and epinephrine (17).  The increase in glucagon and epinephrine also 
causes a reduction in insulin secretion (17).  The declining insulin concentrations 
allow for increased lipolysis and ketogenesis (25,26,28,38), allowing adaptation to 
occur to maintain lean body mass (25,26,28).  If starvation continues to the point 
where 50% of body protein stores have been used, the oxidation of lipids and the 
levels of ketones in the body are decreased (25).  The resting metabolic rate also 
decreases, after an initial increase, when triiodothyronine and catecholamine levels 
decrease (28).  If this process is not stopped, the eventual outcome will be death 
(25).     
Although the need was pointed out in 1998 (39), there are no standards of 
nutritional status that allow investigators to choose experimental animal models to 
mimic specific categories of human PEM.  In the absence of such information, the 
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parameters used to assess protein-energy status in animal models are typically 
decreased body weight, feed intake(40), serum albumin (6) and liver glutathione (40-
42), and increased liver lipid (42).  The two common experimental models of PEM 
in rodents are restricted intake of a nutritionally complete diet and ad libitum 
consumption of a low-protein diet (39).  Previously, a gerbil model of PEM has been 
characterized for use in global ischemia studies in our laboratory (9,10).  In this 
model of PEM, gerbils fed a low protein diet (2% protein) voluntarily reduce their 
feed intake, making the model a combination of both protein and energy 
malnutrition (9,10).  Feeding the 2% protein diet for 4 weeks in the gerbil previously 
induced a 17%, 15%, and 49% reduction in body weight, feed intake, and liver 
glutathione, respectively, as well as a 66% increase in liver lipids compared to 
controls (9,10).   
2.3 Mechanisms of Ischemic Brain Damage 
The mechanisms that cause damage following ischemic stroke are 
excitotoxicity, peri-infarct depolarizations, oxidative stress, inflammation and 
programmed cell death or apoptosis (13,43).  Disruption of cerebral blood flow 
interrupts the delivery of oxygen and glucose, which are substrates the brain needs 
for energy production (13,44).  When cellular energy decreases, the cells in the 
brain, neurons and glia, depolarize (13,44).  This causes the activation of voltage-
gated Ca2+ channels and the release of excitatory neurotransmitters, such as 
glutamate (13,44).  Glutamate accumulates in the extracellular space which causes 
the activation of NMDA receptors and metabotropic glutamate receptors which also 
leads to Ca2+ efflux (13,44).  Na+ and Cl- enter neurons due to extracelluar glutamate 
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accumulation (13,44).  This is followed by water rushing into cells which causes 
edema (13,44).  Activated leukocytes cause the activation of phospholipase and 
cyclooxygenase (COX) which causes the generation of free radicals (13,44).  
Activated phospholipase also causes the upregulation of leukotrienes, eicosanoids, 
prostaglandins and platelet-activating factor which leads to vasoconstriction and a 
subsequent increase in platelet aggregation (44).  Increased free radical generation 
under ischemic circumstances exhausts endogenous scavengers of free radicals (13).  
This leads to lipid peroxidation and cell membrane damage (13).  Oxygen free 
radicals also trigger the initiation of the inflammatory response and apoptosis (13). 
There are two categories of human ischemic stroke (43,45).  Focal stroke is 
when there is a loss of blood flow, due to a clogged artery, in a focalized area of the 
brain (43,45).  Global ischemia occurs when there is a complete loss of blood flow to 
a hemisphere of the brain, which is what happens during cardiac arrest (43,45).  
Although global ischemia models, such as the one used in this thesis, have been 
criticized for mimicking cardiac arrest rather than focal stroke, they share many of 
the same pathophysiological mechanisms (43,46) yet provide more consistent injury 
(47).  Thus animal models of global ischemia are often used to investigate problems 
relevant to patients with focal ischemia.  As described below, the pathophysiological 
mechanisms of interest in this thesis, oxidative stress, inflammation, and reactive 
gliosis are all present in models of global ischemia (48) although inflammation to a 
lesser degree than in focal ischemia (49).  
Primary damage from brain ischemia begins with a disruption of blood flow 
to the brain, which results in the depletion of  oxygen and glucose, necessary 
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substrates for the production of ATP, thus depleting the brain’s supply of ATP (50-
52).  The depletion of ATP leads to the reduced activity of ATP-dependent ion 
pumps, in particular, Na+/K+-ATPase, which leads to membrane depolarization (50-
52).  Reduction in Na+/K+-ATPase activity leads to an increase in extracellular K+ 
and intracellular Na+, Cl- and Ca2+ (50-52).  The influx of Ca2+ leads to an increased 
release of excitatory amino acids, such as glutamate (50,51).  The excess glutamate 
over-stimulates NMDA receptors and leads to Na+, Cl- , Ca2+ and water 
accumulation which leads to cellular swelling and cytotoxic edema (50,51).  The 
increase in intracellular Ca2+ leads to the activation of phospholipase A2, COX, 
neuronal nitric-oxide synthase (nNOS) and inducible nitric-oxide synthase (iNOS), 
which consequently produce free radicals (50).  Excess intracellular Ca2+ also leads 
to a calcium overload in mitochondria, inhibited ATP production, breakdown of 
macromolecules such as phospholipids, proteins and nucleic acids (51).   
Secondary brain damage occurs hours or days after the initial ischemic event, 
and is when symptoms worsen and brain damage progresses (52).  Transient global 
ischemia can give rise to delayed neuronal cell damage or death, which is the case in 
the CA1 region of the hippocampus following global ischemia (52).   
2.3.1  Role of Cytokines and Glial Cells in Global Ischemia 
An inflammatory response has been found in approximately 75% of acute 
stroke patients (53).  Prolonged inflammation in acute stroke has been associated 
with a poor prognosis (53).  Following an ischemic episode, leukocyte adhesion 
molecules such as intercellular adhesion molecule (ICAM)-1, P-selectin, and E-
selectin are rapidly induced on microvascular endothelium (44).  Peripheral 
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inflammatory cells can migrate into the CNS after the leukocyte adhesion molecules 
adhere to the microvascular endothelium (54).  Proinflammatory cytokines are 
produced by activated leukocytes (44).  Cytokines are also produced secondary to 
ischemia and reperfusion (55).  Endothelial cell exposure to cytokines such as 
tumour necrosis factor (TNF)-α and interleukin (IL)-1β upregulate ICAM-1, E-
selectin and leukocyte adhesion molecule generation (54-56).   
Inflammation is a major component of the brain damage caused in global 
ischemia.  In a study by Saito et al. (57), female Mongolian gerbils underwent 
bilateral common carotid artery occlusion, and regional levels of TNF-α, IL-1β and 
interleukin (IL)-6 were measured by enzyme-linked immunoassays.  After 5 minutes 
of occlusion, the greatest increase in cytokine concentration compared with shams 
was found in the hippocampus at 6 hours post-reperfusion.  Peripheral immune cells 
usually do not migrate into the damaged CNS before 24 hours post-ischemia in 
global ischemia models as they do in focal ischemia (45); therefore these early 
increases in cytokine concentrations are most likely due to activated microglia and 
astrocytes.  In another study, male and female Mongolian gerbils were subjected to 
10 minutes of bilateral common carotid artery occlusion (58).  Localization of IL-6, 
which has been shown to have neuroprotective effects, was examined using 
immunohistochemistry and Western blot analysis.  IL-6 was localized in the CA1 
region of the hippocampus, peaked at 3-6 hours after reperfusion, and then steadily 
declined until 3 days, by the last measurement at 7 days, only a few IL-6 
immunoreactive cells remained.  Activated astrocytes were shown to increase from 
24 hours to 3 days after reperfusion in the CA1 cell layer.  These activated 
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astrocytes, detected by increased numbers of GFAP positive astrocytes, did not 
demonstrate IL-6 immunoreactivity.  IL-6 immunoreactivity was also found to 
significantly decrease at 12 hours after reperfusion.  This decrease is most likely due 
to CA1 vulnerability to injury.  COX-2 is induced by inflammation, 
proinflammatory cytokines and reactive oxygen species (ROS) (59).  Maslinska et 
al. (60) found COX-2 immunopositive hypertrophic astrocytes around the edges of 
the necrotic tissue in human brains of patients that had died 2 or more weeks after 
resuscitation from global ischemia.      
Reactive gliosis, which is caused by brain injury, is an increase in the size of 
the astrocyte cell body and its processes accompanied by an increase in GFAP (61).  
Reactive gliosis also causes both astrocytes and microglia to proliferate around the 
site of injury (62).  There is considerable controversy as to whether astrocytes and 
microglia are protective or detrimental in brain injury.  The end product of reactive 
gliosis is the glial scar, which is composed mainly of astrocytes, and may possibly 
function to isolate the region of injury from healthy neural tissue (62). Microglia are 
often activated before the activation of astrocytes which suggests that microglia may 
be a trigger for reactive gliosis (61).  In the rat brain, microglia respond within the 
first 20 minutes after transient global ischemia (63).  After 2-4 days, neural damage 
is obvious in the CA1 region of the hippocampus and the microglia are activated 
further which worsens the inflammatory response (63).  Proinflammatory cytokines 
induce the activation of glial cells, which then produce cytokines (64).  Despite some 
studies showing the temporal response of microglia and astrocytes to ischemic injury 
up to 7 days following global ischemia (65-68), the temporal response from the time 
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following ischemia to a later time point, such as 10 days post-ischemia has not yet 
been shown, and the effect of PEM on microglial and astrocytic activation following 
global ischemia is not yet known.   
Whether astrocytes provide a protective role for neurons and/or an injurious 
role is controversial (69).  Astrocytes release compounds such as neurotrophins 
which are protective (69). On the other hand, astrocytic swelling, which occurs early 
after ischemia in humans, is a cause of delayed neuronal death (62).  Activated 
microglia stimulate inflammation and secrete toxic compounds such as TNF-α, IL-
1β and NO which promote neuronal injury (69,70).  Chronic neurological stress 
causes microglia to become activated by both the signal produced by the injury and 
inflammatory cells (70).  The activated microglia secrete proinflammatory 
compounds and chemokines which cause other microglia to migrate to the area (70).  
This process perpetuates the damage (70).  Microglia can also transform into 
macrophages and present antigens to T cells (49). 
Reactive gliosis is a general feature of rodent models of global ischemia 
(67,68,71).  This reactive gliosis has also been described in a number of studies 
using the gerbil model of bilateral common carotid artery occlusion (48,66,69,72).  
Kato et al. (69) looked at astrocyte and microglial activation in gerbils that 
underwent 2 minutes of ischemic preconditioning, a brief ischemic insult that does 
not produce significant brain damage and protects the brain from later ischemic 
insults, before a 3 minute ischemic episode, compared with animals that had a sham 
operation followed by the 3 minutes of ischemia.  In animals with ischemic 
tolerance, the animals that have had the ischemic preconditioning, there were 
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moderate increases in astrocyte and microglial staining.  After the 3 minute ischemic 
episode in the preconditioned animals, GFAP staining increased in the hippocampus.  
The animals without ischemic tolerance had microglial activation with pronounced 
staining using isolectin-B4 from Griffonia simplicifolia, followed by neuronal 
destruction by day 7 post reperfusion, whereas preconditioned animals had no CA1 
neuronal injury.  This suggests that astrocyte activation may be protective in the 
CA1 hippocampal region.  Another study (66) looked at whether doxycycline and 
monocycline, which are antibiotics with anti-inflammatory properties, had 
neuroprotective effects.  Male Mongolian gerbils were subjected to 6 minutes of 
bilateral common carotid artery occlusion.  They found that minocycline blocked the 
activation of microglia and reduced the induction of iNOS.  They found no 
difference in astrogliosis between treated and non-treated animals.  This 
demonstrates that microglia have more injurious effects in global ischemia than 
astrocytes.  Liu et al. (72) found pronounced microglial/macrophage proliferation 
after 5 minutes of bilateral common carotid occlusion in male Mongolian gerbils.  
The length of ischemia in these animals caused the death of most of the CA1 
pyramidal neurons.  They also found microglia throughout the CA3 region and 
dentate granule cell neuron layer, which is normally resistant to global ischemia 
(12).   
Domanska-Janik et al. (48) looked at the role of nuclear factor (NF)-κB, a 
protein transcription factor which promotes the transcription of a number of pro-
inflammatory molecules (48), in activation of glial cells.  Mongolian gerbils 
underwent bilateral common carotid artery occlusion followed by 3-4 days of 
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reperfusion.  They found that GFAP levels were near control levels for the first 24 
hours, and the strongest reaction was seen at day 7 post reperfusion in the CA1 
hippocampal region.  Ricinus communis agglutinin (RCA)-120 lectin staining for 
microglia was apparent in the first 24 hours in the CA1 region of the hippocampus 
and had increased by day 3.  The apoptotic neurons had disappeared by day 7, but 
GFAP and RCA-120 lectin were still expressed by astrocytes and microglia, 
respectively.   They also found that NF-κB levels were increased early in the CA1 
region.  This demonstrates a relationship between NF-κB and the early activation of 
microglia in the CA1 region of the hippocampus.   
2.3.2  Proposed Mechanism of Influence of PEM on Brain Damage in Stroke 
Our laboratory has previously shown that protein-energy malnourished 
gerbils that were subjected to global ischemia had significantly worse behavioural 
outcomes, as assessed by open field, when compared to ischemic animals fed control 
diet (10).  An open field test is conducted by placing animals in a novel environment 
3-5 days post-ischemia, animals that fail to habituate to this environment by 
decreasing their activity levels, are assessed as having functional deficits in the CA1 
region of the hippocampus (12).  Although PEM did not worsen the loss of 
hippocampal CA1 neurons at day 10 post-ischemia, one third of the PEM animals 
showed marked gliosis that completely disrupted the CA1 pyramidal neuron region.  
Sections immunostained with anti-glial fibrillary acidic protein (GFAP) antibody 
suggested that this subset of PEM ischemic animals had a large population of 
reactive astrocytes (unpublished observations).  A limitation of this study is that the 
hippocampal sections had first been stained with hematoxylin and eosin (H & E).  
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This reduced sensitivity such that it was not possible to immunohistochemically 
detect whether there were also increased numbers of activated microglia present.  
Reactive astrocytes and microglia can cause an increased inflammatory response 
post-ischemia (49,67,69,73).  Therefore, increased reactive gliosis post-ischemia, if 
confirmed, may be indicative of an increased inflammatory response in PEM (10).   
In order to ascertain the effect of PEM on astrocyte and microglial activation 
following global ischemia, this study needs to be repeated with appropriate tissue 
sections.   
One potential mechanism by which PEM may increase the inflammatory 
response of the brain to stroke is by increasing activation of the protein transcription 
factor, NF-κB.  NF-κB, which promotes transcription of proinflammatory molecules, 
is found in all cell types (74,75).  Proinflammatory molecules transcribed by NF-κB 
include ICAM-1, iNOS, COX-2, IL-1β, IL-6 and TNF-α (74). Activated NF-κB has 
been found in high concentrations in brain tissue of rodent stroke models (75).  
Recently, a colleague in our laboratory, using the bilateral common carotid artery 
occlusion model of global ischemia in the gerbil, has shown that PEM, independent 
of ischemia, causes increased NFκB, as assessed by electrophoretic mobility shift 
assay, activation at 6hr post-surgery, and a trend at 24hr towards an increase (76).  
Li et al. (77) examined the effect of lipopolysaccharide (LPS), a bacterial endotoxin, 
on inducing NF-κB activation in the liver of protein-malnourished mice.  They 
found that mice with protein malnutrition had significantly increased activation of 
NF-κB and also increased levels of its transcription products IL-1β and TNF-α.  This 
study also found that early supplementation with N-acetylcysteine (NAC), a cysteine 
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pro-drug that has been found to increase reduced-glutathione (GSH) levels, to 
protein malnourished mice normalized the GSH levels and the activation of NF-κB.  
GSH is an endogenous antioxidant that has been found to decrease in tissues, such as 
liver, lung, colon, heart and spleen, under conditions of protein malnutrition (77,78).  
Brain concentrations of glutathione in protein-malnourished gerbils are not reduced, 
which may indicate that the brain has tighter control over glutathione concentrations 
than other body tissues (10).  Although brain glutathione concentration remains 
unchanged in PEM, there may be increased oxidative stress driving NF-κB 
activation, independent of glutathione (10).  In support of this idea, increased 
inflammatory mediators, such as IL-6, C-reactive protein, the soluble receptors for 
TNF-α, and leukotrienes, have been reported in children with PEM (79,80).  PEM 
has also been associated with an increased inflammatory response in patients with 
chronic obstructive pulmonary disease, chronic heart failure, chronic renal failure 
and rheumatoid arthritis (81). 
2.4  Animal Models of Stroke 
Animal models of brain ischemia are crucial to the study of stroke because 
they can be controlled, produce reproducible results and are important for studying 
the mechanisms involved in ischemia (82,83).  Treatments for cerebral ischemia also 
need to be tested and proven safe and effective in animal models prior to being 
tested in clinical trials (84).   
2.4.1  Animal Models of Focal and Global Ischemia 
Animal models of ischemia can be classified as either focal or global (82-84).  
Rodents are used to study brain ischemia because of low cost, homogeneity between 
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strains, similarity of cerebrovascular anatomy to that of higher species, small brain 
size, and their use is more ethically acceptable than the use of higher species (82).  
Physiological monitoring is important in all models of brain ischemia to ensure 
accurate and reproducible results (82-84).   
Focal ischemia more closely mimics what is seen in human stroke (82-84).  
The most widely used model of focal ischemia is the occlusion of the middle 
cerebral artery (MCAO) in the rat, which can be either transient or permanent (82-
84).  MCAO produces a targeted infarct in the area where the artery would normally 
deliver blood flow as well as a penumbra surrounding the necrotic tissue that is 
potentially salvageable (82-84).  The middle cerebral artery can be either clipped or 
ligated transcranially, postorbitally or transorbitally, which are all invasive and 
require surgery (82-84).  Recently, intraluminal methods of MCAO have replaced 
the more invasive methods (82-84).  This method involves the placement of fine-
nylon threads with a silicon-thickened tip into the external carotid artery to obstruct 
the flow of blood to the middle cerebral artery (82-84).  This model can become 
transient by the removal of the threads (82-84).   
Global ischemia is usually transient and affects tissue more globally than the 
focal models (82-84).  Global ischemia mimics human cardiac arrest more than 
human stroke (82-84).  As noted above, focal stroke and global ischemia share many 
of the same pathophysiological mechanisms, with the benefit of global ischemia 
models providing more consistent injury (82-84).  A widely used model of global 
ischemia has been the bilateral common carotid artery occlusion (BCCAO) in the 
gerbil.  This involves clamping the bilateral common carotid arteries for a 
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predetermined period of time followed by the removal of the clamps to allow 
reperfusion (82-84).  This model allows for delayed neuronal death (82-84).  In rats, 
the two-vessel occlusion of the bilateral common carotid arteries produces global 
ischemia when combined with systemic hypotension (82-84).  This model also 
produces delayed neuronal death (82-84).  The major disadvantage of this model is 
that because of the hypotension, physiological variables are more difficult to control 
(82-84).  The four-vessel occlusion model of forebrain ischemia is another model of 
global ischemia used in the rat (82-84).  This method is technically more difficult, 
but is applied to freely moving, awake animals (82-84).  This procedure requires 2 
stages (82-84).  The first stage has a high fatality rate and involves the permanent 
occlusion of the anterior vertebral arteries by electrocauterization under anaesthesia 
as well as the placement of a clasp around the bilateral common carotid arteries that 
is placed through a ventral midline neck incision (82-84).  One day later, forebrain 
ischemia is produced by the tightening of the clasps around the bilateral common 
carotid arteries (82-84).  These clasps are removable if reperfusion is desired (82-
84).  Due to the high degree of technical difficulty of this procedure, the failure rate 
can be as high as 25% (82).   
2.4.1.1  Gerbil Model of Global Ischemia 
Historically, the bilateral common carotid artery occlusion (BCCAO) in the 
gerbil was an excellent model of global ischemia due to the gerbil’s incomplete 
Circle of Willis.  The gerbil lacked posterior communicating arteries such that 
BCCAO led to delayed neuronal cell death and severe forebrain ischemia that was 
reproducible with low variability (11,82-84).  The gerbil model had also been 
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characterized for functional outcome (behavioural) tests, including the open field 
and the t-maze, and has the advantage of being less invasive (12,83).   The latter 
translates into less of a stress response in the animal which is important for use in 
nutritional studies (12,83).   
Recently, variability in neuronal cell death in the gerbil BCCAO model has 
been increasing and has led to the discovery that a high percentage of these animals 
are developing posterior communicating arteries that are large enough to allow for 
significant blood flow, thereby completing the Circle of Willis (11,85).  A recent 
study conducted using gerbils from two different suppliers, Charles River and High 
Oaks, showed that gerbils from these suppliers had bilateral or unilateral posterior 
communicating arteries in 61% and 16%, respectively (11).  Ischemic gerbils from 
High Oaks showed 95% loss of CA1 hippocampal neurons, while gerbils from 
Charles River showed only a 71% loss of CA1 hippocampal neurons (11).  Also, in 
open field testing, High Oaks gerbils exposed to BCCAO showed impaired 
habituation on days 3, 7, and 10 post-ischemia, while gerbils from Charles River did 
not, and performance in the open field predicted the CA1 hippocampal neuronal loss 
(11).  A study using gerbils from the two suppliers in the United States, Charles 
River and Harlan Sprague-Dawley, found that 90% of their gerbils had posterior 
communicating arteries (85).  These studies demonstrated a definite need to screen 
gerbils for severity of ischemia following BCCAO in order for the model to continue 
to be used.   
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2.4.1.1.1  Post-Ischemic Hyperactivity as a Screening Tool for Severity of 
Ischemia 
 Directly following the ischemic episode, there is a period of inactivity that 
lasts from when the animal regains consciousness and their righting reflex for about 
30 minutes to a few hours (11).  Immediately following this phase, there is a period 
of persistent hyperactivity that can last for several days post-ischemia depending on 
the severity of the ischemic episode (11).  Gerbils with a severe ischemic insult 
display consistent hyperactivity during this period (11,86,87).  Therefore, an 
effective, non-invasive method of screening for complete ischemia would be to 
monitor post-ischemic activity.  Another objective of this thesis describes validation 
of a method of screening for complete ischemia based on hyperactivity.  
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CHAPTER 3.  MATERIALS AND METHODOLOGY 
3.1  Animals and Diet 
Male Mongolian gerbils (Meriones unguiculatus, Charles River Canada, Saint-
Constant, QC, Canada), aged 11-12 weeks, were acclimated for 3-7 days, and then 
randomized to control (CON, n=44) or protein deficient (n=45) pelleted diets (Dyets, 
Inc., Bethlehem, PA, USA), which contained 12.5% and 2% protein as casein (10), 
respectively (Table 3.1).  When gerbils are fed this low protein diet, they voluntarily 
reduce their feed intake, making them both protein and energy malnourished (PEM) 
(10).  During the acclimatization period (4-7d), the animals were all kept on the 
basal (CON) diet.  The basal diet was modified from the American Institute of 
Nutrition (AIN)-93M rodent diet (88) to contain no tertiary- butylhydroquinone, an 
antioxidant.  Animals were housed in climate controlled facilities on a 12 hour 
light/dark cycle in shoebox cages with CareFRESH® (Absorption Corp, 
Bellingham,WA, USA) bedding in groups of three or four with free access to feed 
and water.  During the 28 day feeding period, weekly body weights (OHAUS, Triple 
Beam Balance 700 Series 2610 g, Florham Park, NJ) and daily feed intakes 
(Sartorius 1401 MP 1500,0 g, Germany) were recorded. The white pelleted diet was 
easily seen and removed from the dark bedding in order to measure feed spillage.  
Body weights were also recorded on the final day of the study.  All animal care and 
procedures were in accordance with the Canadian Council on Animal Care 
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guidelines (89) and were approved by the University of Saskatchewan Committee on 
Animal Care and Supply.     
 
Table 3.1. Modified AIN-93M Rodent Diet¥ 
Component Adequate Protein§ 
(Control, CON) g/kg 
Protein Deficient§§ (PEM) 
g/kg 
Vitamin free casein 140 22.4 
L-cysteine 1.8 0.29 
Sucrose 100 100 
Cornstarch 465.7 543.049 
Dextrinized cornstarch 155 181.001 
Soybean oil 40 40 
Cellulose 50 50 
Mineral mix* 35 35** 
Calcium phosphate dibasic 0 12.4 
Calcium carbonate 0 3.36 
Vitamin mix¶ 10 10 
Choline bitartrate 2.5 2.5 
¥Diet formulation provided by Dyets, Inc.  
§Control diet was formulated to contain 12.5% protein, 10% fat, 78% carbohydrate.  
§§PEM diet was formulated to contain 2% protein, 10% fat, 88% carbohydrate. 
*AIN-93M mineral mix (88). 
**AIN-93M modified mineral mix: calcium and phosphate deleted, potassium citrate increased from 
28 to 226.55g/kg, sucrose increased from 209.806 to 618.256g/kg mineral mix. 
¶AIN-93M vitamin mix (88). 
 
 
3.1 Surgical Procedures 
At day 28, animals underwent 5 minutes of bilateral common carotid artery 
occlusion or a sham surgery as described by Dowden and Corbett (90), generating 
four experimental groups (Figure 3.1): 1)  Control-Sham (CON-S) (n=12); 2) 
Control-Ischemic (CON-I) (n=32); 3) PEM-Sham (PEM-S) (n=12); 4) PEM-
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Ischemic (PEM-I) (n=32).  Each group had outcome measures after ischemia (n = 8) 
or sham (n=3) surgery at 4 timepoints: 6hr, 24hr, 3d and 10d.  Animals were 
anaesthetized with 1.5–2.0% isoflurane with 1L/min oxygen, at which time rectal 
and tympanic membrane temperature probes were inserted.  The rectal probe with a 
homeothermic blanket (Harvard Apparatus Canaday, Saint-Laurent, QC, Canada) 
was used to monitor core body temperature and keep the animal warm during 
anesthesia.  The tympanic probe (Barnant Type T Digi-Sense Thermometer) with a 
Mul-T-Pad® water-heated blanket wrapped around the head was used to 
approximate and maintain the brain temperature at 36.5 ± 1.4°C, with a 6 point 
average between 36.3°C and 36.7°C.    During the surgical period, under 
anaesthesia, a ventral midline incision was made and the common carotid arteries 
were isolated by passing silk surgical thread under both arteries; this allowed for 
gentle lifting of the arteries.  Upon stabilization of tympanic temperature, the arteries 
were occluded with micro-aneurysm clips that provided 60g of pressure (World 
Precision Instruments Inc., Sarasota, FL, USA) for five minutes.  Occlusion of blood 
flow was visually assessed.  During the five minute occlusion, core and tympanic 
temperatures were monitored continuously and recorded once a minute.  After 5 
minutes the clips were removed and blood reflow through the carotid arteries was 
visually assessed.  The incision was then closed using Novafil™ sutures (4-0) and 
Xylocaine® 2% was used as a topical analgesic.  Sham surgeries were identical with 
the exception of artery occlusion.  Immediately following removal from the 
anesthetic machine, animals were individually placed in a recovery cage under a red 
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40 watt bulb for two hours; once mobile, animals had the choice to access the lamp 
or not.   
Figure 3.1.  Overview of experimental factorial design. The time-points refer to times at 
which brains were collected for immunohistochemistry. 
 
3.2 Animal Activity Monitoring 
Since gerbils with complete global ischemia show persistent hyperactivity (86), 
this characteristic was used to screen out animals with incomplete ischemia.  
Immediately following the two hour recovery period, all animals having outcome 
measurements at 24hr, 3d, and 10d post-surgery had their activity monitored and 
recorded for 20 hours.  The animals with outcome measurements at 6hr were 
monitored for 4 hours only.  Activity was monitored using Opto-M3 Activity Meter 
(Columbus Instruments, Columbus, OH, USA).  This equipment uses infrared 
sensing on a 16"x16" grid to detect the movement of the animals.  Activity data were 
collected at 15 minute intervals for the duration of the monitoring period.  Animals 
had access to both feed and water during this period.  After the allotted monitoring 
period, animals were returned to their home cage, or in the case of the six hour time 
point, immediately perfused.    
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To screen out animals with incomplete ischemia, the following two criteria were 
proposed and applied to gerbils subjected to bilateral common carotid artery 
occlusion:  
1) Individual mean activity/20hr of these gerbils had to be greater than three 
standard deviations above the mean activity of a sham group.  The rationale for 
this criterion is that, assuming a normal distribution, the mean + 3 standard 
deviations will encompass greater than 99% of the sham population (91).  Data 
from a study conducted by Colbourne et al. (87) also suggests that ischemic 
gerbils would be correctly classified on the basis of this criterion.  The area 
under the curve for the activity pattern over 20 h was also tested in place of mean 
activity/20h, but identified the same animals for exclusion. 
Mean (± SD) activity of sham animals in our laboratory is 190 ± 155 counts/20hr 
(n=30, combined data from experiments of J. Ji and M. Harmon).  Both PEM 
and CON shams were included in deriving this value because only ischemia 
affects activity values (Data from the 2 combined experiments: p<0.001; PEM-I, 
n = 35; CON-I, n = 32; PEM-S, n = 15; CON-S, n = 15;), while there is no effect 
of PEM (p= 0.875 ) nor is there an interaction between ischemia and PEM (p= 
0.686).   
2)  Activity had to be persistently elevated over the course of the monitoring 
period (86).  The rationale for this criterion is that gerbils with incomplete 
ischemia can have high initial activity that subsequently decreases (11).   
Animals that did not meet these criteria were screened out of the experimental 
group for immunohistochemical and histological assessment.   
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The 6h animals could have activity monitored for only 4 hours, which was 
deemed an insufficient amount of time to assess ischemic severity since the 
persistence of the hyperactivity could not be assessed (86).  Consequently, all 6h 
animals were included in the results.  In interpreting the results, it was taken into 
account that these animals would likely have a variable ischemic insult.     
3.3 Assessment of Protein-Energy Malnutrition 
Assessment of PEM was previously defined in the group fed the protein-
deficient diet in our laboratory on the basis of reduced feed intake, body weight, and 
liver glutathione, and elevated liver lipid (10).  In the current study, PEM was further 
characterized by measuring serum albumin concentration.  Blood was collected by 
cardiac puncture at 3 days post-ischemia before tissue perfusion and allowed to sit 
on the bench top at room temperature for 30 minutes to coagulate.  Blood was then 
spun for 10-15 min at 1500 x g before harvesting serum to be frozen at -80°C until 
all samples were collected and sent to Prairie Diagnostic Services Veterinary 
Clinical Pathology Laboratory for analysis.  Serum albumin was analyzed using the 
bromcresol green methodology (92) of detection on a Hitachi 912 colorimeter 
(Hitachi, Ltd., Japan).   
3.4 Immunohistochemistry 
At 6hr, 24hr, 3d and 10d post-surgery, animals were anaesthetized with 4.5-
5.0% isoflurane with 1L/min oxygen and perfused trans-cardially at 10 mL/min with 
heparinized saline for 4 minutes followed by 4% paraformaldehyde for 8 minutes.  
Heads were then removed and placed in jars with 4% paraformaldehyde for 24 
hours.  Brains were then removed and placed in jars of 4% paraformaldehyde until 
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they were sent for paraffin embedding, at which point they were placed in phosphate 
buffered saline (PBS) (pH 7.4) until processing.  Brain processing was conducted by 
the Histology Laboratory in the Department of Veterinary Biomedical Sciences.  
After paraffin embedding, brains were sectioned using a microtome to 10µm and 
placed on Precleaned Superfrost® Plus slides (VWR International).  Consecutive 
sections of the entire hippocampus were taken for each immunostain.  For each time 
point, sections were stained with antibodies to glial fibrillary acidic protein (GFAP) 
(DAKO, Denmark), a marker of astrocytes (48,61), and biotinylated ricinus 
communis agglutinin I (RCA-120) (Vector Laboratories, Burlingame, CA, USA), a 
marker of activated microglia (93,94).  Sections were also stained with antibodies 
against the cytokine tumour necrosis factor-alpha (TNF-α) (Biosource International, 
Camarillo, CA, USA).  Approximately 18 sections per antibody were examined to 
draw conclusions.  As a result of moving the tissue sections from the water bath to 
the slide, at times the sections show tissue folds. 
Sections were first incubated overnight at 4°C in 10% horse serum (Vector 
Laboratories, Burlingame, CA, USA) to block non-specific reactions, followed by 
overnight incubation at 4°C in the respective primary antibody at dilutions of 1/500 
for rabbit polyclonal anti-bovine GFAP, 1/200 for RCA-120 and 1/500 for rabbit 
polyclonal anti-mouse TNF-α.  With the exception of sections being stained for 
RCA-120, all sections were incubated in biotinylated goat anti-rabbit secondary 
antibody diluted 1/1000 (Vector), followed by incubation in H2O2 to quench 
endogenous peroxidase activity and washing in PBS (pH 7.4).  Sections were then 
incubated in avidin-biotin peroxidase (ABC, Vector Laboratories, Burlingame, CA, 
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USA) and the peroxidase reaction was visualized using 3,3’-diaminobenzidine 
tetrachloride and hydrogen peroxide from the DAB Substrate Kit for Peroxidase 
(Vector Laboratories, Burlingame, CA, USA).  NiCl2 from the DAB Substrate Kit 
for Peroxidase was used to intensify staining only for RCA-120.  Both RCA-120 and 
TNF-α protocols required antigen retrieval, techniques used to unmask antigens after 
fixation (95), using citrate buffer (96) and pepsin (97), respectively.  For citrate 
buffer antigen retrieval, citrate buffer was heated in an oven to 50°C, at which point 
the rehydrated sections were added and the solution was then heated to 90°C and left 
for 25 minutes.  Sections were allowed to cool down before continuing with 
immunohistochemistry.  For the pepsin antigen retrieval, rehydrated sections were 
incubated for 15 minutes at room temperature with 2mg/ml pepsin in 0.1N HCl.  
After each method of antigen retrieval, sections were washed in PBS prior to 
continuing with immunohistochemistry.  The specificity of the immunoreactions was 
verified by incubating sections without the primary antibody.   
Other antibodies to pro-inflammatory cytokines were also tested on brain 
sections from the gerbil, but the results were not of high enough quality to proceed.  
One potential reason is paraffin embedding of tissue sections.  Markers of 
proinflammatory cytokines that were tried without success were rabbit anti-mouse 
polyclonal COX-2 (Cayman Chemical, Ann Arbor, MI, USA), rabbit monoclonal 
COX-2 (Clone SP21) (Lab Vision Corporation, Fremont, CA, USA), rabbit 
polyclonal anti-mouse IL-1β (Serotec, Oxford, UK), mouse monoclonal iNOS 
(Clone NOS-IN) (Sigma, St. Louis, MO, USA), as well as another iNOS antibody 
(Santa Cruz, Santa Cruz, CA, USA).   All antibodies were used as described in 
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methods for immunohistochemistry using antigen retrieval with alterations in 
protocol being made as follows: 1)  primary antibody concentration; 2)  length of 
blocking time; 3)  length of time for incubation in ABC; 4)  with and without NiCl2; 
5)  length of incubation time for secondary antibody; and 6) citrate buffer, trypsin, 
and pepsin antigen retrieval methods.   
3.5 Histology 
Every tenth section of the brains collected at 10d post-surgery for 
immunohistochemistry was dedicated for histological analysis.  Sections were 
placed on gelatin subbed slides and stained with hematoxylin and eosin (H&E).  The 
investigator was blinded to slide identity to avoid bias.  Viable neurons, non-
eosinophilic cells with a defined cell membrane and nucleus, were counted 
bilaterally at 400x magnification using a 200µm square grid (10 x 10) at the median, 
middle and lateral sectors of the CA1 region of the hippocampus at levels ‘A’ 
(anterior, ~-1.7mm from bregma), and ‘B’ (middle, ~-2.2mm from bregma), and in 
the middle sector at level ‘C’ (posterior, ~-2.7mm from bregma) at 400x 
magnification, in order to cover the anterior-posterior axis of the hippocampus 
(Figure 3.2), as previously described (10).   
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Figure 3.2.  Hippocampal CA1 neuron regions for histological assessment (98).  
 
3.6 Validation of Activity Screening for Complete Ischemia 
To validate the method of activity screening proposed to identify complete 
ischemia, the activity data from the 10d animals were checked against the 
hippocampal CA1 neuron counts from the same animals.   
3.7 Statistics 
When quantitative data were collected post-surgery, statistics were performed 
using a 2-way analysis of variance (ANOVA), which tested for independent effects 
from ischemia and PEM as well as the interaction between ischemia and PEM.  Pre-
surgery feed and weight data were analyzed using unpaired T-test.  Statistical 
significance was set at the level of p<0.05.  Post-surgery feed data are shown 
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descriptively because sample size was insufficient for statistical analysis.  Statistics 
were analyzed using SPSS for Windows version 13.0.   
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CHAPTER 4.  RESULTS 
4.1  Feed Intake and Weight Gain 
 Initial body weight did not differ between control and PEM groups (p= 
0.183) (Table 4.1).  At day 28, PEM animals had significantly lower body weight 
when compared to the control group (p< 0.001), and had lost 12.2% of their initial 
body weight.  Average feed intake in the PEM group per animal per cage (n=2-4 
animals/cage) was 10.7% lower than that of the control group for the 28 day feeding 
period; this difference was significant (p< 0.001).   
 
Table 4.1. Effect of diet on pre-ischemic body weight and feed intake 
 Control PEM 
Initial Body Weight (g) 62.3 ± 0.5 (44) 63.2 ± 0.4 (45) 
Body Weight on day 28 
(g) 
65.7 ± 0.5 (44) 55.4 ± 0.5 (45)* 
Feed Intake/28d (g)¶ 108.5 ± 1.8 (11) 96.9 ±1.6 (12)* 
Mean ± SEM(n). 
* p<0.05, significance determined by unpaired student’s t-test. 
¶ Average feed intake per animal per cage (2-4 animals/cage). 
 
Table 4.2 shows body weight data by cage for the post-ischemic period.  At 
6h and 10d post-ischemia only PEM significantly decreased body weight.  At 3d 
post-ischemia, both PEM and ischemia independently decreased body weight.  There 
was no interaction between diet and ischemia.  The data from the 24h PEM-S 
animals was not collected; therefore statistics could not be performed on the 24h 
post-surgery group.  Figure 4.1 shows feed intake post-ischemia for animals from 
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the 10d time-point.  Feed intakes of ischemic and sham animals fed control diet had 
returned to normal by 3-4 days post-surgery.  Feed intake of PEM ischemic and 
sham animals remained depressed post-surgery.  The pattern of feed intake in 
animals from the 1d and 3d time-points was similar (data not shown).  Animals from 
the 6hr time-point ate on average 0-0.1g during the 6 hours.   
 
Table 4.2. Pattern of body weight (g) post-ischemia*  
Time-point PEM-I PEM-S CON-I CON-S 
6hr¶ 54.9 ± 0.9 (8)  57.2 ± 0.7 (3)  63.9 ± 1.2 (8) 63.7 ± 2.6 (3) 
24hr 53.5 ± 1.4 (8) ___ † 62.5 ± 1.4 (8) 65.9 ± 0.8 (3) 
3d¶§ 51.9 ± 1.2 (8)  53.7 ± 2.0 (3) 59.2 ± 3 (4) 67.6 ± 1.8 (3) 
10d¶ 49.4 ± 0.8 (9)  52.3 ± 0.7 (3)  68.1 ± 1.6 (8) 66.3 ± 1.2 (3) 
*Mean ± SEM(n) 
¶ Significant effect of PEM determined by 2-way ANOVA (p<0.05). 
§Significant effect of ischemia determined by 2-way ANOVA (p<0.05). 
† Data were not collected for this group. 
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Figure 4.1. Pattern of 10d post-ischemic feed intake.  Average feed intake/day was 
calculated as total feed intake/day/number of animals per cage (I, n=4; S, n=3). For comparison at 
time 0, average intake/animal/day during the 28d pre-ischemia feeding period was 3.5g/d for PEM 
and 3.8g/d for CON groups.   
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4.2  Serum Albumin 
 Mean (±SEM) serum albumin concentration (g/L) at 3d post-surgery were as 
follows:  PEM-I, 28.5 ± 0.5; PEM-S, 28.1 ± 0.5; CON-I, 34.8 ± 0.5; CON-S, 33.8 ± 
0.5.  Protein-energy malnutrition decreased serum albumin by 17.8% (p<0.001), 
while ischemia had no effect.  There was no interaction between the two 
independent variables. Table 4.3 shows serum albumin concentrations for individual 
animals for all experimental groups.  The variability within groups was small. 
 
Table 4.3.  Serum albumin concentration (g/L) for individual animals 
PEM-I 29 29 29 28 29 27  
PEM-S 29 29 27 29 29 28 26 
CON-I 34 33 36 35 35 36  
CON-S 36 33 32 33 35   
 
4.3  Activity Monitoring 
4.3.1 Screening for Complete Ischemia 
Ischemic animals that remained in the study after screening were :  10d PEM-I, 
n = 7;  10d CON-I, n = 5; 3d PEM-I, n = 8; 3d CON-I, n = 5; 24h PEM-I, n = 5; 24h 
CON-I, n = 3.  However, unfortunately, the activity data from 7 of these animals 
were lost (3 animals from the 10d PEM-I group and 4 animals from the 3d CON-I 
group).  Immunohistochemical data from these 7 animals were still examined.  Of 
these 7 animals, 4 had unilateral damage as determined by inspection of the H&E 
stained CA1 region of the hippocampus, one from the 10d PEM-I group and 3 from 
the 3d CON-I group.  Using the exclusion criteria, 70% of the animals screened were 
labeled as truly ischemic.  Table 4.4 shows individual animal inclusions or 
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exclusions on the basis of mean activity/20hr.  Figure 4.2 shows the hippocampus of 
a 10d animal with incomplete ischemia, in which one side of the hippocampus has 
an intact CA1 region and the other side of the hippocampus has almost complete 
damage to the CA1 region. 
4.3.2  Validation of Exclusion Criteria 
 
From the 16 ischemic animals at 10d, activity monitoring was collected for 13; 
the data from 3 animals were lost.  After examining the CA1 neuronal cell counts, 
11/13 animals were correctly classified by our screening protocol.  For the two 
errors, one was a false positive and one was a false negative result.  That is, one 
animal was excluded on the basis of activity but had complete bilateral and extensive 
damage on histological assessment.  One animal was included but had only 
unilateral damage detected by histology.  Our method of screening for complete 
ischemia thus had an 84.6% success rate.   
4.4 Hippocampal CA1 Neuron Cell Counts 
Ischemia significantly reduced the total number of surviving CA1 neurons 
(p<0.001), whereas PEM had no effect (p = 0.091) (Figure 4.3 and 4.4).  There was 
no interaction between diet and surgery (p=0.972).   The increased number of H&E 
stained glia apparent in the PEM sections is due to inter-ischemic variation and is 
not representative of the effect of PEM.  The statistical results for the individual 
hippocampal levels were identical to those for the total cell counts (Table 4.5).  The 
temporal loss of CA1 neurons following ischemia is demonstrated in Figure 4.5.  
There were no apparent differences between PEM animals and those fed the CON 
diet.   
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Table 4.4.  Individual study inclusions and exclusions on the basis of activity  
Animal# Activitya Pass/Fail Animal# Activitya Pass/Fail 
10d PEM-I 3d CON-I 
C1L-7 1657 Pass C2L-1 570 Fail 
C1N-7 423 Fail C2N-1 508 Fail 
C1R-7 924 Pass C2R-1 2397 Pass 
C2N-7 1681 Pass C2B-1 507 Fail 
C2R-7 2310 Pass C2N-2 N/A Pass 
C1N-2 N/Ab Pass C2B-2 N/A Pass 
C1B-2 N/A Pass C2R-2 N/A Pass 
C1R-2 N/A Pass C2L-2 N/A Pass 
10d CON-I 1d PEM-I 
C1R-3 328 Fail C3R-3 1524 Pass 
C1L-3 3292 Pass C3B-3 543 Fail 
C1B-3 3433 Pass C3L-3 1013 Pass 
C1N-3 438 Fail C3N-3 95 Fail 
C1N-4 973 Pass C3L-4 1086 Pass 
C1L-4 4284 Pass C3R-4 3200 Pass 
C1R-4 2004 Pass C3N-4 1297 Pass 
C1B-4 237 Fail  
3d PEM-I  1d CON-I 
C2R-5 2150 Pass C4L-1 506 Fail 
C2B-5 1340 Pass C4B-1 72 Fail 
C2L-5 1773 Pass C4R-1 2300 Pass 
C2N-5 1338 Pass C4N-1 112 Fail 
C2L-6 2584 Pass C3N-2 544 Fail 
C2R-6 2136 Pass C3L-2 3500 Pass 
C2N-6 2457 Pass C3B-2 2259 Pass 
C2B-6 1630 Pass C3R-2 450 Fail 
a Mean counts/20h. 
bData not available. 
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Figure 4.3. Total hippocampal CA1 neurons at 10d post-ischemia. Data are expressed 
as mean ± SEM.  There was a significant effect of ischemia detected by 2-way ANOVA (p<0.05).  
 
 
 
 
 
Figure 4.4.  Comparison of PEM and CON hippocampus at 10d post-
ischemia.  A = PEM-I, A' = PEM-S, B = CON-I, B' = CON-S.  Arrow indicates 
tissue fold.  Scale bar = 150µm. 
A 
B
A'
B'
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Table 4.5.  Neuronal cell counts at individual sectors of the hippocampal CA1 
region  
 PEM-Sa PEM-Ib CON-Sa CON-Ic 
Level A* 389 ± 8 95 ± 24 348 ± 26 60 ± 8 
Level B* 440 ± 40 111 ± 27 389 ± 14 61 ± 9 
Level C* 145 ± 18 46 ± 10 130 ± 5 28 ± 5 
Total* 974 ± 66 252 ± 59 867 ± 42 149 ± 19 
Mean ± SEM; a n= 3, b n= 7, c n= 5. 
*Significant effect of ischemia determined by 2-way ANOVA (p<0.05). 
 
4.5 Immunohistochemistry 
 
Semi-quantification of the immunohistochemical results was not undertaken 
due to variability in staining among slides.  Temporal expression of GFAP and 
RCA-120 following global ischemia was demonstrated (Figures 4.6 and 4.7 and 
Figures 4.8 and 4.9, respectively).  Figures 4.6 and 4.8 show higher magnification 
photographs of the hippocampus and Figures 4.7 and 4.9 show lower magnification 
photographs of the CA1 region of the hippocampus.  PEM did not cause any 
apparent increase in expression of GFAP or RCA-120 compared to controls (Figures 
4.6-4.9).  Although reactive gliosis was demonstrated, the pronounced reactive 
gliosis previously seen in a subset of ischemic protein-energy malnourished gerbils 
in our laboratory was not demonstrated.  PEM also did not appear to cause obvious 
earlier activation of glial cells, or prolong their activation. 
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Figure 4.5.  Temporal loss of hippocampal CA1 neurons 
following global ischemia.  A-E, PEM; A'-E', CON. A-D and A'-
D', ISCH; E and E', Sham.  A, A' = 6hr, B, B' = 24hr, C, C' = 3d, D, D' = 
10d, and E, E' = 10d.  Arrow indicates H&E stained glial cell.  
Differences in H&E stained glia between PEM and CON are due to 
picture selection.  Scale bar = 100µm. 
A A'
B'
C'
D'
E'E 
D 
C 
B 
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E'E 
D'D 
C'C 
B'B 
A'A 
Figure 4.6.  Temporal expression of GFAP in the 
CA1 hippocampal region following global ischemia.  
A-E, PEM; A'-E', CON. A-D and A'-D', ISCH; E and E', Sham.  
A=6hr, B=24hr, C=3d, D=10d, and E=10d.  Arrow indicates 
GFAP stained astrocyte.  Scale bar = 100µm. 
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Figure 4.7.  Expression of GFAP in the hippocampus at 10d post-
ischemia.  A and B, ISCH; A' and B', Sham. A, PEM; B, CON. Scale bar = 150µm. 
A'A 
B B'
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E'E 
D' D 
C'C 
B'B 
A' A 
Figure 4.8.  Temporal expression of RCA-120 in the 
CA1 hippocampal region following global ischemia.  
A-E, PEM; A'-E', CON. A-D and A'-D', ISCH; E and E', Sham.  
A=6hr, B=24hr, C=3d, D=10d, and E=3d.  Arrow indicates 
RCA-120 stained microglia.  Scale bar = 100µm. 
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Figure 4.9.  Temporal expression of RCA-120 in the 
hippocampus following global ischemia.  A-E, PEM; A'-
E', CON. A-D and A'-D', ISCH; E and E', Sham.  A=6hr, 
B=24hr, C=3d, D=10d, and E=3d.  Scale bar = 150µm. 
A A'
B B'
C C'
D D'
E E'
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Astrocytes and microglia are seen throughout the hippocampus.  For GFAP, 
expression was at its peak at 10d post-ischemia (Figure 4.7).  Expression of GFAP at 
6h and 24h was slightly more than that seen in shams, and noticeably different than 
staining in shams by 3d post-ischemia (Figure 4.6).  The morphology of astrocytes 
had obviously changed by 10d post-ischemia; the astrocytes at this time-point were 
hypertrophic, which is typical of reactive astrocytes (69,99).  Expression of RCA-
120 was at its peak at 3d post-ischemia (Figures 4.8 and 4.9).  RCA-120 expression 
was slightly more than seen in sham animals at 6h post-ischemia, and had slightly 
increased by 24h.  By 10d post-ischemia, expression of RCA-120 had almost 
completely returned to sham levels.  The morphology of microglia at the 6hr and 
24hr time-points was that of early activated microglia, and by 3d had changed to 
bushy activated microglia (100). 
Temporal expression of TNF-α following global ischemia was also 
demonstrated in the hippocampus (Figure 4.10) and hippocampal CA1 region 
(Figure 4.11).  TNF-α immunoreactivity was seen in the neurons of the CA1, CA2 
and CA3 regions of the hippocampus and the dentate gyrus in all sham animals 
(Figure 4.11).  The staining was similar at all time-points in sham animals.  At 6h 
post-ischemia, TNF-α was no longer expressed in the CA1 neurons of the 
hippocampus, but was still present in the CA2 and CA3 neurons and dentate gyrus.  
Expression of TNF-α slowly returned to the CA1 neurons of the hippocampus at 24h 
and 3d post-ischemia.  By 10d post-ischemia the death of neurons in the CA1 region 
of the hippocampus is nearly complete (Figure 4.5), and accordingly the expression 
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of TNF-α was no longer seen in the CA1 neurons at this time-point.  There was no 
apparent effect of PEM on expression of TNF-α in either sham or ischemic groups.   
 
 
 
 
 
 
 
Figure 4.10.  Temporal expression of TNF-α in the hippocampus following global 
ischemia.  A-D, PEM-I; E-H, CON-I; I-L, CON-S.  A, E, I=6hr, B, F, J=24hr, C, G, K=3d, and 
D, H, L=10d.  Scale bar = 150µm. 
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Figure 4.11.  Temporal expression of TNF-α in the CA1 hippocampal region 
following global ischemia.  A-D, PEM-I; E-H, CON-I; I-L, CON-S.  A, E, I=6hr, B, F, 
J=24hr, C, G, K=3d, and D, H, L=10d.  Scale bar = 100µm. 
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CHAPTER 5.  DISCUSSION 
Previously, our laboratory had shown that a subset of gerbils with PEM that 
had undergone 5 minutes of BCCAO had what appeared to be a dramatic 
exacerbation of reactive gliosis in the hippocampal region of the brain (9).  The 
major goal of the current study was to confirm these results and investigate the 
extent of astrocytic versus microglial activation.  A second goal was to determine 
whether PEM also exacerbated inflammation, as measured by TNF-α, in response to 
global ischemia.   
In order to replicate and expand these findings, an identical feeding protocol 
and experimental design were utilized.  Previously our laboratory had shown that a 
2% protein diet fed for 28d caused mild to moderate PEM assessed by reduced feed 
intake, body weight and liver glutathione, and elevated liver lipid (9).  To verify the 
mild to moderate PEM that was previously seen in this model, both feed intake and 
body weight were measured in this study.  Both were depressed in the pre-surgical 
period as well as following surgery in both sham and ischemic groups fed the 2% 
protein diet.  To further characterize this model of PEM, serum albumin was 
measured in the current study and found to be reduced by 17.8%.  Serum albumin is 
generally not decreased in early PEM because of its long half-life of 14-20 days 
(18).  As PEM progresses, and protein depletion worsens, serum albumin 
concentration, along with that of other serum proteins, decreases because of 
decreased protein synthesis (17).   
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Exposure to ischemia decreased feed intake in both PEM and CON groups 
up to 3 days post-surgery.  Accordingly, ischemia independently decreased body 
weight by the 3d time-point.  Sham surgery caused a smaller depression in feed 
intake in the CON group with little weight loss.  After 3 days, the feed intake of all 
CON animals, both sham and ischemic, returned to normal, and their body weights 
started to increase.  Post-ischemic body weight and feed intake are important 
variables to measure in rodent models of stroke, as they may influence the extent of 
brain damage, but they are not often reported. 
In order to undertake the major research objectives, it was necessary to 
develop methodology for identifying those animals that had a severe ischemic insult 
so that others could be screened out of the study.  This became necessary because of 
recent published evidence for a high incidence of a full or partial Circle of Willis 
that makes the variability in ischemic insult unacceptably high in gerbils 
commercially available in North America (11,85).  Thus, a third goal of this study 
was to validate criteria for identifying persistent hyperactivity against hippocampal 
CA1 neuronal cell counts that could serve as a noninvasive method for screening for 
complete global ischemia in the gerbil.  Using the criteria that hyperactivity would 
be defined as activity greater than 3 standard deviations above the mean activity of a 
sham group resulted in correct identification of complete ischemia in 84.6% of 
cases.  Of the 2 of 13 animals that were incorrectly classified, one was a false 
positive and one a false negative.  Although it does not frequently occur, gerbils with 
severe global ischemia can sometimes have damage in the striatal area of the brain, 
and these animals can show decreased activity despite extensive damage to the 
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hippocampal CA1 region (101); although striatal damage was not evaluated, this 
may explain the false negative result.  Since the sample size used for validation was 
relatively small, it is possible that the accuracy of the criteria for identifying 
complete ischemia has been either over- or underestimated.    
For those laboratories continuing to use the gerbil BCCAO model of global 
ischemia, the method of screening for complete global ischemia developed here 
would be a very good option for decreasing the variability in CA1 hippocampal 
neuron death occurring when animals have either a full or partial Circle of Willis.  
One limitation of this method is that it does not work for assessing outcome in the 
first few hours after global ischemia since evidence must be obtained that activity is 
persistently elevated.  This is because gerbils with incomplete ischemia can have 
high initial activity that subsequently decreases (86).  In this experiment, animals at 
the 6hr time-point were monitored for 4hr following ischemia so that they would be 
treated in the same manner as the rest of the experimental groups.  However, these 
data were not used to assess ischemic insult in these gerbils, and thus the 
immunohistochemical data collected at this early time-point suffers from this 
limitation.  A more precise method, that would also allow for animals to be assessed 
at any post-ischemic time-point is Doppler flowmetry as suggested by Laidley and 
colleagues (11).  This technique ensures blood flow is sufficiently reduced in the 
brain region of interest.  Even if one of these methods is used to reduce variability, a 
high number of animals will be unusable and this will lead to unnecessary costs and 
use of animals.  For short-term studies, for example, when doing follow-up work to a 
previous study done in the gerbil, these methods would be practical.  To continue 
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using the gerbil model of global ischemia in the long term, however, a colony of 
gerbils would need to be bred which consistently have an incomplete Circle of 
Willis.  The other, and more practical, option is to switch to rat global ischemia 
models of 2- or 4-vessel occlusion (82,84).        
The influence of PEM on the temporal response of astrocytes and microglia 
to global ischemia was demonstrated for the first time in this study at 6hr, 24hr, 3d 
and 10 d post-ischemia.  GFAP staining was at its peak at 10d following ischemia.  
Expression was slightly increased over what was seen in shams at 6 and 24hr post-
ischemia, with a larger increase by 3d post-ischemia.  This pattern has been 
previously demonstrated in the BCCAO model of global ischemia in the gerbil (48).  
By 10d post-ischemia, the morphology of the astrocytes was hypertrophic, as is 
typical of reactive astrocytes (69,99).  Expression of RCA-120 peaked at 3d post-
ischemia, as has been previously documented  following global ischemia in the 
gerbil (48).  At 6hr post-ischemia, RCA-120 staining was slightly higher in ischemic 
animals than in shams, and at 24hr following ischemia, this difference was more 
noticeable.  By 10d, RCA-120 staining in ischemic animals had returned to sham 
levels.  The morphology of the microglia at 6hr and 24hr post-ischemia was that of 
early activated microglia, and by 3d, this had changed to bushy activated microglia, 
which is what is described in the literature (100). 
Under the conditions of this study, PEM did not exacerbate reactive gliosis 
compared to CON animals.  There was no obvious increase in staining of astrocytes 
or microglia nor did PEM hasten or prolong the rate of activation of glial cells 
compared to CON animals.  These findings are contrary to those previously 
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described in our laboratory by Bobyn et al. (9).  There are a number of possible 
explanations for the disagreement between the two studies, as both have limitations.  
After excluding animals with incomplete ischemia in the current study, the sample 
size may have been too small to see an effect of PEM on reactive gliosis, particularly 
since Bobyn et al. (9) reported the observation in only one third of the 12 ischemic 
animals with PEM.  The quality of the immunohistochemistry in the current study 
was not high enough to use quantitative methods to assess the degree of staining or 
to count astrocytes and microglia.  This may have detected a small effect of PEM 
that could be missed visually.  Although brain temperature is monitored and 
controlled during the ischemic period in our laboratory, a limitation of both studies 
was the inability to monitor brain or core temperature during the post-ischemic 
period.  Proper control of brain temperature both during and after brain ischemia is 
crucial because hypothermia (32-34˚C) is neuroprotective (82,83,86,87,98,102) and 
hyperthermia aggravates the neuronal damage (102).  It is possible that the subset of 
PEM animals with marked reactive gliosis from the previous study had post-
ischemic hyperthermia, causing a more marked glial response.  Another difference 
between the two studies is that regulation of brain temperature during the ischemic 
period in the current study was not kept in as narrow a range as in the study by 
Bobyn et al. (9).  Although it is possible that this masked a marked glial response, 
there was no bias in temperature regulation between the PEM or CON groups, and 
the brain temperatures recorded in the current study were well above what is 
considered mild hypothermia and below the hyperthermic range.  Finally, the results 
from the current study, with the exception of data collected at 6hr following 
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ischemia, may be seen as more reliable since animals were screened for complete 
ischemia and removed from the study if they did not meet criteria.  Although the 
previous study conducted in our laboratory was conducted before the prevalence of a 
complete Circle of Willis was as high in the gerbil, Bobyn et al. (9) used all animals 
regardless of completeness of ischemia, although variability in the model was clearly 
increasing.  Another limitation of both studies is the use of young gerbils.  The 
majority of the population that suffers from stroke are elderly, and there are 
differences in outcome between young and old animals (103).  Therefore, a future 
direction should be to use aged animals.    
Given the limitations of the gerbil model of global ischemia, a rat model of 
global ischemia, either the 2- or 4-vessel occlusion model (82,84), should be used to 
confirm whether or not reactive gliosis is exacerbated by PEM post-ischemia.  There 
are more markers for glial cells validated for use in the rat.  Staining of microglia 
with RCA-120 in the gerbil gives less than optimal immunohistochemistry.  Other 
markers of microglia that could be used in the rat are OX42 and ED1, both of which 
have been tested in the rat and give clear results (63,104).  Another possibility to 
improve the quality of immunohistochemistry would be to use frozen sections 
instead of paraffin embedded sections.          
In agreement with the previous study published from our laboratory (9), 
PEM did not exacerbate hippocampal CA1 neuronal loss at 10d following global 
ischemia in the gerbil.  However, Bobyn et al. (9,10) reported that animals with 
PEM had significantly worse behavioural outcomes, as assessed by open field 
testing, compared to the CON animals.  It is known that neurons can remain viable 
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after a brain insult, but not be able to function properly (12).  In this model of global 
ischemia, CA1 neurons have delayed cell death, and these viable neurons could be 
functionally abnormal prior to death or remain functionally abnormal but alive (12).  
Therefore, the functional results reported are more meaningful than the neuronal cell 
counts in relation to neuronal damage (12).  More functional testing is indicated in 
future studies to fully understand the extent of the abnormalities in PEM following 
global ischemia.  Whether functional impairments persist beyond the recovery 
period is also of interest.    
TNF-α immunoreactivity was employed as a single marker of inflammation 
in this study and was seen in all sham animals in the neurons of all hippocampal 
regions.  There was no detectable difference between the CA1 hippocampal neurons 
and the other neurons of the hippocampus, in all sham animals.  The pattern of 
staining is similar to what has previously been reported in the rat (105,106).  One 
study found that sham animals showed TNF-α immunoreactivity in the CA1 through 
CA3/hilar regions of the hippocampus, dentate gyrus, cortex and corpus callosum,  
as well as a weak TNF-α mRNA signal in the same brain regions, as well as the 
caudate putamen.  There was an even stronger signal for the mRNA of the  TNF-α 
receptor, TNFR1, in the entire hippocampus of sham animals (106).  A second study 
in rats showed that sham animals had a few scattered TNF-α  immunoreactive cells 
in the hippocampus (105).  Some possible explanations for the differences of TNF-α 
immunoreactivity seen in sham animals between studies are differences in animals 
used, either species or strain, differences in tissue processing and the antibody used 
(106).   
 63
At 6hr post-ischemia, the TNF-α immunoreactivity had disappeared from the 
CA1 neurons of the hippocampus, but was still present in the CA2 and CA3 neurons 
and dentate gyrus.  Staining was again seen in the CA1 neurons at 24hr and was still 
present at 3d post-ischemia.  By 10d post-ischemia, the majority of neurons in the 
CA1 region of the hippocampus have died, and accordingly, the TNF-α staining was 
also gone, but remained in the CA2 and CA3 neurons and the dentate gyrus.  In a rat 
2-vessel occlusion model of global ischemia in which animals are exposed to 20 
minutes of bilateral common carotid artery occlusion combined with hypotension, 
Sairanen et al. (106) reported peak TNF-α mRNA expression at 8hr post-
reperfusion, with a decrease to that of shams by 24hr after reperfusion.  However, 
neuronal TNF-α immunoreactivity following global ischemia was similar to that of 
sham animals (106).  One explanation given for the mismatch between protein and 
mRNA levels is that the mRNA following ischemia may not be as stable for 
translation into protein (106).  Also, it was suggested, that the TNF-α, if attached to 
its receptors, might not be as available to the antibody (106).  These findings are in 
contrast to those obtained using a cruder model of transient global ischemia in which 
the intensity of the TNF-α immunoreactivity increased and reached its peak at 3d 
post-ischemia (107).  A third study using a mouse model of 20 minutes of bilateral 
common carotid artery occlusion reported that hippocampal TNF-α mRNA 
expression was increased at 3hr post-ischemia, returned to control levels and then 
was increased again by 36hr post-ischemia (107).  Contrary to our findings, they 
found that TNF-α protein levels were only significantly elevated compared to shams 
at 6 hours post- ischemia, as was TNFR1 protein (57).  In the one study investigating 
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TNF-α immunoreactivity in a 5-minute global ischemia gerbil model, it was 
reported, using enzyme-linked immunoassay, that TNF-α immunoreactivity was 
only elevated in the hippocampus only at 6hr post-ischemia (57).  This study also 
examined 10 minutes of global ischemia, which caused TNF-α immunoreactivity to 
increase in the hippocampus by 1hr post-ischemia, with a return to sham levels by 
12hr, and an increase again at 24hr post-ischemia (106).  However, a 10-minute 
occlusion period generally results in post-ischemic seizures (12), which confounds 
the results.  As this was the only other study looking at TNF-α expression after 5 
minutes of BCCAO in the gerbil, we expected to see similar results.  Although this 
was not the case, there were limitations in the data collected in the current study.  
This included inconsistencies related to technical problems in sectioning and 
staining, which also made it unclear as to when expression was the highest following 
global ischemia.   
Contrary to our hypothesis, PEM did not appear to alter the pattern of TNF-α 
immunoreactivity in sham animals at any time-point following global ischemia.  
This suggests that the inflammatory response to global ischemia is not increased as a 
result of PEM.  Recently, a colleague in our laboratory, using the same model 
described here, has shown that PEM, independent of ischemia, causes increased 
NFκB activation at 6hr post-surgery, and a trend at 24hr towards an increase (76).  
TNF-α is one pro-inflammatory molecule whose transcription is increased by NFκB 
(74).  Therefore, the finding here, that PEM has no effect on TNF-α 
immunoreactivity was surprising.  As an increase in TNFR1 has been reported 
following global ischemia in the rat, it is possible that increased TNF-α 
 65
immunoreactivity was not detected because it was already bound to its receptor 
(106).  Conclusions are also limited since only one marker of inflammation was 
employed, and future studies should examine additional inflammatory markers such 
as IL-1β and COX-2.  The finding that PEM did not alter the pattern of TNF-α 
immunoreactivity, however, is consistent with the finding that PEM did not increase 
reactive gliosis following global ischemia.  As previously discussed, reactive 
astrocytes and microglia can cause an increased inflammatory response post-
ischemia (49,67,69,73)     
In conclusion, the influence of PEM on the temporal development of 
microglia and astrocytic activation was investigated along with TNF-α, as a marker 
of inflammation, in the hippocampus following global ischemia in the gerbil.  The 
data suggest that PEM neither alters glial activation nor increases the inflammatory 
response after global ischemia.  However, the results are not definitive due to 
limitations of the study, including small sample size after excluding animals with 
incomplete forebrain ischemia and inability to quantify immunohistochemical 
results.  A model of screening animals for complete forebrain ischemia on the basis 
of persistent hyperactivity was successfully validated against 10d hippocampal CA1 
neuronal cell counts.  The finding of Bobyn et al. (9,10) that PEM does not 
exacerbate hippocampal CA1 neuronal cell death at 10d following global ischemia 
was confirmed.  Due to the current high incidence of a Circle of Willis in the gerbil 
(11,85), an alternate animal model of ischemia will need to be used in future studies 
investigating the mechanisms by which PEM worsens functional outcome, as has 
been previously reported in both gerbils (4,5,8) and humans (11,85).          
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